Pacific Biosciences Of California (PACB) EBT Margin Growth (3y) (2013 - 2026)
Pacific Biosciences Of California (PACB) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 329.00 |
| 10 | Pacific Biosciences Of California | 426.62 Mn | 150.66 Mn | 12.84 Mn | 20,450.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,450.00 |
| Dec 31, 2025 | 21,853.00 |
| Sep 30, 2025 | 14,036.00 |
| Jun 30, 2025 | 9,594.00 |
| Mar 31, 2025 | -90,195.00 |
| Dec 31, 2024 | 19,607.00 |
| Jun 30, 2024 | -34,680.00 |
| Mar 31, 2024 | -7,901.00 |
| Dec 31, 2023 | -41,792.00 |
| Sep 30, 2023 | -1,505.00 |
| Jun 30, 2023 | -904.00 |
| Mar 31, 2023 | -1,485.00 |
| Dec 31, 2022 | -24,192.00 |
| Sep 30, 2022 | -10,690.00 |
| Jun 30, 2022 | -9,966.00 |
| Mar 31, 2022 | -5,841.00 |
| Dec 31, 2021 | -2,917.00 |
| Jun 30, 2021 | -3,093.00 |
| Mar 31, 2021 | 427.00 |
| Dec 31, 2020 | 36,098.00 |